Related Experiment Video
Updated: Feb 19, 2026

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases
Sylvia Merkert1,2,3, Ulrich Martin4,5,6
1Department of Cardiothoracic, Transplantation and Vascular Surgery, Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover, Germany.
Induced pluripotent stem cell (iPSC) technology and gene editing tools like CRISPR enable precise genome manipulation in human stem cells. This review covers current applications and future challenges for regenerative medicine and research.
Area of Science:
- Biotechnology
- Stem Cell Biology
- Genetics
Background:
- Induced pluripotent stem cell (iPSC) technology has revolutionized regenerative medicine.
- Site-directed nucleases (ZFNs, TALENs, CRISPR/Cas9) allow precise genome manipulation.
- Human pluripotent stem cells (PSCs) are key for disease modeling and therapy development.
Purpose of the Study:
- To review current applications of site-specific nucleases in human PSCs.
- To highlight trends and challenges in efficient gene editing.
- To discuss improvements in targeting strategies for gene editing in PSCs.
Main Methods:
- Review of scientific literature on gene editing in human PSCs.
- Analysis of ZFNs, TALENs, and CRISPR/Cas9 technologies.
- Discussion of gene editing applications including knockouts, transgenesis, and point mutations.
Main Results:
- Gene editing in human PSCs enables creation of disease models and potential therapies.
- CRISPR/Cas9 offers a fast and precise method for genomic modifications.
- Efficient gene editing and improved targeting strategies are crucial for clinical translation.
Conclusions:
- Site-specific nucleases significantly advance regenerative therapies and biomedical research.
- Further optimization of gene editing techniques is needed for widespread clinical application.
- Precise genomic manipulation in PSCs holds great promise for treating genetic diseases.
Related Concept Videos
CRISPR/Cas9 Genome Editing
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
In-vitro Mutagenesis

